The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Apr. 16, 2024
Filed:
Jul. 12, 2022
Applicant:
Ai Therapeutics, Inc., Guilford, CT (US);
Inventors:
Henri Lichenstein, Guilford, CT (US);
Sean Landrette, Meriden, CT (US);
Peter Ronald Young, Short Hills, NJ (US);
Jonathan M. Rothberg, Miami Beach, FL (US);
Assignee:
OrphAl Therapeutics Inc., Guilford, CT (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/5375 (2006.01); A61K 9/00 (2006.01); A61K 31/4152 (2006.01); A61K 31/428 (2006.01); A61K 31/496 (2006.01); A61K 31/5377 (2006.01); A61K 31/66 (2006.01); A61K 31/675 (2006.01); A61K 45/06 (2006.01); A61P 25/00 (2006.01); A61P 25/08 (2006.01); A61P 25/28 (2006.01);
U.S. Cl.
CPC ...
A61K 31/5377 (2013.01); A61K 9/0053 (2013.01); A61K 31/428 (2013.01); A61K 45/06 (2013.01); A61P 25/00 (2018.01); A61P 25/08 (2018.01); A61P 25/28 (2018.01);
Abstract
Provided are compositions and methods related to the use of apilimod in combination with glutamatergic agents for treating neurological diseases and disorders, and for the treatment of cancer.